Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (5797)	10/23/1998 11:30:00 AM
From: Vector1	Read Replies (2) \| Respond to of 9719

No problem doubling CYTO's comp and giving him a piece of the action. In fact we should change the name to VD&C model portfolio. Just promise me this is the last AMLN trade. AMLN is a black eye on the industry. They abused capital with poorly designed studies and achieved crappy results. There are numerous companies with great science and quality people who can't get funded. The AMLN's of the world are driving up the cost of capital. Kinda like insurance cheats driving up premiums. I am off my soap box for now. Great to hear from Andy again. Yes GZTC whould be a winner but they have a long way to go. As AGPH continues to rise what do you think of selling some out of the money covered calls. V1